This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Naloxone and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (33)
Death (4)
Life Threatening Events (6)
Disability (1)
Reports by Reaction Type
Confusional State (5),
Accidental Overdose (5),
Bradykinesia (5),
Drug Withdrawal Syndrome (5),
Bradyphrenia (5),
Dyskinesia (4),
Pulmonary Oedema (4),
Toxicity To Various Agents (4),
Anxiety (4),
Diarrhoea (4),
Chills (3),
Hypertension (3)
Below are a few examples of reports where side effects / adverse reactions may be related to Naloxone. For a complete list or a specific selection of reports, please use the links above.
Possible Naloxone side effects in
Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-08-20
Patient:
Reactions: Neonatal Respiratory Depression, Hypotonia Neonatal, Foetal Exposure During Pregnancy, Tachypnoea, Bradycardia Neonatal
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Remifentanil
Dosage: 3.3 microg/min
Indication: General Anaesthesia
Remifentanil
Dosage: 20 microg/min
Naloxone
Dosage: 0.1 mg/kg
Indication: Neonatal Respiratory Depression
Possible Naloxone side effects in 17 year old male
Reported by a physician from Germany on 2012-07-23
Patient: 17 year old male
Reactions: Dyskinesia, Pulmonary Oedema, Apnoea, Accidental Overdose
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Naloxone
Indication: Accidental Overdose
Clonidine
Indication: Agitation
Levomepromazine
Indication: Agitation
Fentanyl
Dosage: additional boluses for maintenance, total 1.3mg
Haloperidol
Indication: Agitation
Fentanyl
Dosage: 3 microg/kg for induction
Indication: Anaesthesia
Other drugs received by patient: Rocuronium Bromide; Furosemide; Sevoflurane; Norepinephrine; Propofol; Rocuronium Bromide; Propofol
Possible Naloxone side effects in 17 year old male
Reported by a physician from Germany on 2012-06-26
Patient: 17 year old male
Reactions: Dyskinesia, Pulmonary Oedema, Apnoea, Accidental Overdose
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Fentanyl
Dosage: 3 microg/kg for induction
Indication: Anaesthesia
Haloperidol
Indication: Agitation
Levomepromazine
Indication: Agitation
Fentanyl
Dosage: additional boluses for maintenance, total 1.3mg
Clonidine
Indication: Agitation
Naloxone
Indication: Accidental Overdose
Other drugs received by patient: Sevoflurane; Norepinephrine Bitartrate; Propofol; Rocuronium Bromide; Rocuronium Bromide; Furosemide; Propofol
Possible Naloxone side effects in 79 year old female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-04
Patient: 79 year old female
Reactions: Blood Pressure Increased, Vertigo
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Navelbine
Dosage: 2 mg iv
Indication: Breast Cancer
Start date: 2012-03-21
End date: 2012-03-21
Naloxone
Dosage: 5 mg tid
Indication: Pain
Start date: 2012-03-21
End date: 2012-03-28
Possible Naloxone side effects in 83 year old male
Reported by a physician from Canada on 2012-04-20
Patient: 83 year old male
Reactions: Pulse Abnormal, Hypopnoea, Drug Ineffective, Unresponsive To Stimuli, Heart Rate Irregular, Staring, Blood Pressure Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Naloxone
Dosage: 04. mg;x3
Indication: Acute Respiratory Distress Syndrome
Fentanyl Citrate
Dosage: 10 ug;qh ; 2 ug;q15min
Indication: Dyspnoea
Fentanyl Citrate
Dosage: 10 ug;qh ; 2 ug;q15min
Indication: Agitation
Other drugs received by patient: Unspecified Diuretics; Unspecified Antibiotics
Possible Naloxone side effects in female
Reported by a physician from Australia on 2012-04-18
Patient: female, weighing 50.0 kg (110.0 pounds)
Reactions: Dysphoria, Hyperbilirubinaemia, Vomiting, Nausea, Yawning, Chills, Pain, Drug Withdrawal Syndrome, Delirium, Feeling Cold, Anxiety, Malaise, Diarrhoea
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
MS Contin
Dosage: 30 mg, bid
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-04
End date: 2012-01-01
Naloxone
Dosage: 40/20 mg tab daily
Administration route: Oral
Indication: Pulmonary Fibrosis
Start date: 2012-01-31
End date: 2012-01-31
Other drugs received by patient: Loratadine; Nexium; Prednisolone; Sildenafil
Possible Naloxone side effects in male
Reported by a physician from Australia on 2012-04-17
Patient: male
Reactions: Anxiety, Drug Withdrawal Syndrome, Depression, Suicidal Ideation
Drug(s) suspected as cause:
Naloxone
Dosage: 40/20mg daily
Administration route: Oral
Indication: Back Pain
Oxycontin
Dosage: 40 mg, daily
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Oxycodone HCL; Selective Serotonin Reuptake Inhibitors; Diazepam
Possible Naloxone side effects in
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-04-16
Patient:
Reactions: Drug Withdrawal Syndrome Neonatal
Drug(s) suspected as cause:
Celexa
Dosage: 20 mg
Naloxone
Dosage: 15 mg
Start date: 2009-03-30
End date: 2010-01-01
Flexeril
Dosage: 10 mg
Start date: 2009-03-30
End date: 2010-01-01
Diclectin
Start date: 2009-03-30
End date: 2010-01-01
Oxycontin
Dosage: 30 mg
Start date: 2009-03-30
End date: 2010-01-01
Flexeril
Dosage: 20 mg
Start date: 2009-03-30
End date: 2010-01-01
Lidocaine
Start date: 2009-03-30
End date: 2010-01-01
Tramadol Hydrochloride / Acetaminophen
Celexa
Dosage: 40 mg
Clomid
Start date: 2009-03-30
End date: 2010-01-01
Imovane
Dosage: 7.5 mg
Start date: 2009-03-30
End date: 2010-01-01
Naloxone
Dosage: 30 mg
Start date: 2009-03-30
End date: 2010-01-01
Possible Naloxone side effects in 74 year old male
Reported by a physician from Germany on 2012-03-19
Patient: 74 year old male, weighing 90.0 kg (198.0 pounds)
Reactions: Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Novalgin, 1000 MG, Amp, Sanofi-Aventis
Dosage: 2
Start date: 2011-09-22
End date: 2011-09-23
Losartan Potassium
Dosage: lorsartan 50 mg + 12.5 mg hydrochloride
Administration route: Oral
Start date: 1993-01-01
End date: 2011-10-05
Naloxone
Dosage: naloxon 5 mg + oxycodonhydrochloride 10 mg
Administration route: Oral
Start date: 2011-09-22
End date: 2011-10-30
Amoxicillin
Dosage: 3000 milligram;
Administration route: Oral
Start date: 2011-10-05
End date: 2011-10-11
Novalgin, Trpf, Sanofi-Aventis
Administration route: Oral
Start date: 2011-09-22
End date: 2011-10-02
Possible Naloxone side effects in female
Reported by a pharmacist from Australia on 2012-03-16
Patient: female
Reactions: Dyskinesia, Chills, Drug Withdrawal Syndrome, Hyperhidrosis, Tremor, Anxiety, Diarrhoea, Hypertension, Muscle Spasms
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Oxycontin
Dosage: 10 mg, see text
Administration route: Oral
Naloxone
Dosage: unk unk, see text
Administration route: Oral
Indication: Cancer Pain
Start date: 2012-02-16
End date: 2012-02-17
Oxycontin
Dosage: 40 mg, see text
Administration route: Oral
Indication: Cancer Pain
Other drugs received by patient: Vitamin D / 00318501 /; Levothyroxine Sodium; Caltrate with Vitamin D; Rabeprazole Sodium; Cordilox; Ferrograd C; Vytorin; Acetaminophen
Possible Naloxone side effects in
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-03-12
Patient:
Reactions: Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Amoxicillin
Dosage: 3x1 tablet at 1000 mg daily per os
Administration route: Oral
Indication: Pneumonia
Start date: 2011-10-05
End date: 2011-10-11
Novalgin / SCH /
Dosage: 2g i.v. on 22 sep and 1g i.v. on 23 sep 2011
Start date: 2011-09-22
End date: 2011-09-23
Naloxone
Dosage: 1-2 prolonged-release tablets daily per os
Administration route: Oral
Start date: 2011-09-22
End date: 2011-10-30
Losartan Potassium and Hydrochlorothiazide
Dosage: 1x1 tablet daily per os, break: 21-27 sep and 01 oct 2011
Administration route: Oral
Start date: 1993-01-01
End date: 2011-10-05
Novalgin / SCH /
Dosage: 40-80 drops daily per os
Administration route: Oral
Start date: 2011-09-22
End date: 2011-10-02
Possible Naloxone side effects in 60 year old male
Reported by a physician from United States on 2012-03-12
Patient: 60 year old male
Reactions: Toxicity To Various Agents, Drug Withdrawal Syndrome, Stress Cardiomyopathy, Accidental Overdose
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Naloxone
Indication: Toxicity To Various Agents
Methadon HCL TAB
Indication: Drug Abuser
Possible Naloxone side effects in female
Reported by a pharmacist from Australia on 2012-03-07
Patient: female
Reactions: Dyskinesia, Chills, Febrile Neutropenia, Hyperhidrosis, Tremor, Anxiety, Diarrhoea, Hypertension, Muscle Spasms
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Oxycontin
Dosage: 40 mg, see text
Administration route: Oral
Indication: Cancer Pain
Naloxone
Dosage: unk unk, see text
Administration route: Oral
Indication: Cancer Pain
Start date: 2012-02-16
End date: 2012-02-17
Oxycontin
Dosage: 10 mg, see text
Administration route: Oral
Other drugs received by patient: Cordilox; Ferrograd C; Vytorin; Vitamin D / 00318501 /; Levothyroxine Sodium; Caltrate with Vitamin D; Acetaminophen; Rabeprazole Sodium
Possible Naloxone side effects in 47 year old female
Reported by a physician from Switzerland on 2012-03-06
Patient: 47 year old female
Reactions: Bradypnoea, Medication Error, Miosis, Accidental Overdose, Somnolence, Drug Label Confusion
Drug(s) suspected as cause:
Naloxone
Dosage: iv
Start date: 2012-02-16
End date: 2012-02-17
Norcuron
Dosage: 0.1 mg; tid
Start date: 2012-02-16
End date: 2012-02-16
Other drugs received by patient: Methadon HCL TAB
Possible Naloxone side effects in female
Reported by a pharmacist from Italy on 2012-02-28
Patient: female
Reactions: Confusional State, Bradykinesia, Bradyphrenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Naloxone
Dosage: strenght: 10 mg + 5 mg; daily dose: 2 posologic units
Administration route: Oral
Indication: Radiculopathy
Start date: 2011-02-01
End date: 2011-07-11
Zoloft
Dosage: one posologic unit
Administration route: Oral
Indication: Depression
Start date: 2011-02-01
End date: 2011-07-11
Clonazepam
Dosage: 15 anz
Administration route: Oral
Start date: 2006-01-17
End date: 2011-07-11
Pramipexole Dihydrochloride
Dosage: 0.54 mg
Administration route: Oral
Indication: Restless Legs Syndrome
Start date: 2007-04-29
End date: 2011-07-16
Topamax
Dosage: one posologic unit
Administration route: Oral
Start date: 2011-02-01
End date: 2011-07-11
Duloxetine Hydrochloride
Dosage: 60 mg
Administration route: Oral
Start date: 2011-02-01
End date: 2011-07-11
Other drugs received by patient: Coumadin; Nebivolol HCL; Levothyroxine Sodium; Furosemide; Esopral
Possible Naloxone side effects in female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-02-27
Patient: female
Reactions: Confusional State, Bradykinesia, Bradyphrenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clonazepam
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2006-01-17
End date: 2011-07-11
Pramipexole Dihydrochloride
Administration route: Oral
Indication: Restless Legs Syndrome
Start date: 2007-04-29
End date: 2011-07-16
Duloxetine Hydrochloride
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-01
End date: 2011-07-11
Zoloft
Administration route: Oral
Indication: Depression
Start date: 2011-02-01
End date: 2011-07-11
Topamax
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-01
End date: 2011-07-11
Naloxone
Administration route: Oral
Indication: Radiculopathy
Start date: 2011-02-01
End date: 2011-07-11
Other drugs received by patient: Coumadin; Nebivolol HCL; Furosemide; Levothyroxine Sodium; Esopral
Possible Naloxone side effects in female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-02-16
Patient: female
Reactions: Confusional State, Bradykinesia, Bradyphrenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pramipexole Dihydrochloride
Administration route: Oral
Indication: Restless Legs Syndrome
Start date: 2007-04-29
End date: 2011-07-16
Naloxone
Administration route: Oral
Indication: Radiculopathy
Start date: 2011-02-01
End date: 2011-07-11
Duloxetine Hydrochloride
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-01
End date: 2011-07-11
Clonazepam
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2006-01-17
End date: 2011-07-11
Topamax
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-01
End date: 2011-07-11
Zoloft
Administration route: Oral
Indication: Depression
Start date: 2011-02-01
End date: 2011-07-11
Other drugs received by patient: Levothyroxine Sodium; Furosemide; Esopral; Nebivolol HCL; Coumadin
Possible Naloxone side effects in female
Reported by a physician from Italy on 2012-02-09
Patient: female
Reactions: Confusional State, Bradykinesia, Bradyphrenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Topamax
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-01
End date: 2011-07-11
Naloxone
Administration route: Oral
Indication: Radiculopathy
Start date: 2011-02-01
End date: 2011-07-11
Clonazepam
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2006-01-17
End date: 2011-07-11
Zoloft
Indication: Depression
Start date: 2011-02-01
End date: 2011-07-11
Pramipexole Dihydrochloride
Administration route: Oral
Indication: Restless Legs Syndrome
Start date: 2007-04-29
End date: 2011-07-16
Duloxetine Hydrochloride
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-01
End date: 2011-07-11
Other drugs received by patient: Esomeprazole; Levothyroxine Sodium; Coumadin; Furosemide; Nebivolol HCL
Possible Naloxone side effects in 41 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-08
Patient: 41 year old male
Reactions: Polydipsia, Cellulitis, Subcutaneous Abscess, Hyperglycaemia, Polyuria, LIP Pain, Treatment Noncompliance
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Vivitrol
Dosage: not yet randomized nor had received study drug
Indication: Drug Dependence
Naloxone
Dosage: not yet randomized nor had received study drug
Indication: Drug Dependence
Suboxone
Dosage: not yet randomized nor had received study drug
Indication: Drug Dependence
Other drugs received by patient: Albuterol; Glucophage; Lantus; Atenolol
Possible Naloxone side effects in female
Reported by a pharmacist from Italy on 2012-02-08
Patient: female
Reactions: Confusional State, Bradykinesia, Bradyphrenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Naloxone
Dosage: strenght: 10 mg + 5 mg; daily dose: 2 posologic units
Administration route: Oral
Indication: Radiculopathy
Start date: 2011-02-01
End date: 2011-07-11
Clonazepam
Dosage: 15 anz
Administration route: Oral
Start date: 2006-01-17
End date: 2011-07-11
Topamax
Dosage: one posologic unit
Administration route: Oral
Start date: 2011-02-01
End date: 2011-07-11
Duloxetine Hydrochloride
Dosage: 60 mg
Administration route: Oral
Start date: 2011-02-01
End date: 2011-07-11
Pramipexole Dihydrochloride
Dosage: 0.54 mg
Administration route: Oral
Indication: Restless Legs Syndrome
Start date: 2007-04-29
End date: 2011-07-16
Zoloft
Dosage: one posologic unit
Administration route: Oral
Indication: Depression
Start date: 2011-02-01
End date: 2011-07-11
Other drugs received by patient: Coumadin; Esopral; Furosemide; Nebivolol HCL; Levothyroxine Sodium
Possible Naloxone side effects in 19 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-03
Patient: 19 year old female
Reactions: Respiratory Failure, Pulmonary Oedema, Circulatory Collapse, Toxicity To Various Agents
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Methadone HCL
Administration route: Oral
Naloxone
Indication: Reversal of Opiate Activity
Possible Naloxone side effects in 16 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-02
Patient: 16 year old male
Reactions: Respiratory Failure, Circulatory Collapse, Subcutaneous Emphysema, Pulmonary Oedema, Toxicity To Various Agents
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Methadone HCL
Administration route: Oral
Naloxone
Indication: Reversal of Opiate Activity
Possible Naloxone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-31
Patient:
Reactions: Abscess Oral, Hyperglycaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vivitrol
Dosage: unknown if treatment started
Indication: Drug Dependence
Suboxone
Dosage: unknown if treatment with buprenorphine/placebo started
Indication: Drug Dependence
Naloxone
Dosage: unknown if naloxone challenge performed
Indication: Drug Dependence
Possible Naloxone side effects in 60 year old male
Reported by a physician from United States on 2012-01-31
Patient: 60 year old male
Reactions: Agitation, Dyspnoea, Tachycardia, Iatrogenic Injury, Toxicity To Various Agents, Drug Withdrawal Syndrome, Accidental Overdose, Ejection Fraction Decreased, Chest Pain, Hypertension, Electrocardiogram ST Segment Elevation, Stress Cardiomyopathy, Electrocardiogram T Wave Inversion, Lethargy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Naloxone
Dosage: iv
Indication: Toxicity To Various Agents
Methadone HCL
Dosage: po
Administration route: Oral
Indication: Drug Withdrawal Maintenance Therapy
Possible Naloxone side effects in 16 year old male
Reported by a physician from Canada on 2012-01-17
Patient: 16 year old male
Reactions: Agitation, Pneumonia Aspiration, Stridor, Unresponsive To Stimuli, Pneumomediastinum, Blood PH Decreased, Overdose, C-Reactive Protein Increased, Pneumothorax, Pleural Effusion, Epistaxis, White Blood Cell Count Increased, Hypotension, Respiratory Distress, Pulmonary Haemorrhage, Heart Rate Increased, RED Blood Cell Sedimentation Rate Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Naloxone
Dosage: 0.4 mg;x1;iv ; iv
Indication: Overdose
Morphine
Dosage: 3000 mg;x1;po
Administration route: Oral
Indication: Overdose
Possible Naloxone side effects in 37 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-17
Patient: 37 year old male
Reactions: Cardio-Respiratory Arrest, Completed Suicide
Adverse event resulted in: death
Drug(s) suspected as cause:
Naloxone
Dosage: sublingual
Venlafaxine Hydrochloride
Dosage: oral
Administration route: Oral
Lamotrigine
Dosage: oral
Administration route: Oral
Buprenorphine
Dosage: sublingual
Possible Naloxone side effects in 43 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-21
Patient: 43 year old female
Reactions: Asthma, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vivitrol
Start date: 2011-11-16
End date: 2011-11-16
Naloxone
Dosage: naloxone challenge
Indication: Drug Dependence
Start date: 2011-11-01
End date: 2011-11-01
Suboxone
Dosage: two 2 mg or two 8 mg or placebo for around 8 days
Start date: 2011-11-01
End date: 2011-11-01
Vivitrol
Dosage: naltroxone induction
Administration route: Oral
Indication: Drug Dependence
Start date: 2011-11-16
End date: 2011-11-16
Suboxone
Dosage: dose unknown
Indication: Drug Dependence
Start date: 2011-11-01
End date: 2011-01-01
Suboxone
Dosage: 2 mg or 8 mg or placebo
Start date: 2011-11-16
End date: 2011-11-17
Other drugs received by patient: Albuterol; Steroids
Possible Naloxone side effects in 66 year old male
Reported by a health professional (non-physician/pharmacist) from Germany on 2011-12-15
Patient: 66 year old male
Reactions: Myocardial Infarction
Adverse event resulted in: death
Drug(s) suspected as cause:
Doxepin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-01-28
End date: 2011-02-06
Naloxone
Dosage: 160/80 mg
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-01-28
End date: 2011-02-07
Doxepin
Administration route: Oral
Start date: 2011-02-07
Other drugs received by patient: Bisoprolol Fumarate; Pantoprazole Sodium; Exforge; Novalgin
Possible Naloxone side effects in 66 year old male
Reported by a physician from Germany on 2011-12-12
Patient: 66 year old male
Reactions: Myocardial Infarction
Adverse event resulted in: death
Drug(s) suspected as cause:
Doxepin
Dosage: 25 milligram;
Administration route: Oral
Start date: 2011-01-28
End date: 2011-02-06
Naloxone
Dosage: 1 dosage forms; oxycodone hydrochloride +naloxonhydrochloride
Administration route: Oral
Start date: 2011-01-28
End date: 2011-02-07
Doxepin
Dosage: 50 milligram;
Administration route: Oral
Start date: 2011-02-07
Other drugs received by patient: Novalgin; Exforge; Pantoprazole Sodium; Bisoprolol Fumarate
Possible Naloxone side effects in 44 year old male
Reported by a physician from Germany on 2011-12-08
Patient: 44 year old male
Reactions: Gamma-Glutamyltransferase Increased, Sensory Disturbance, Visual Acuity Reduced, Hypoaesthesia, Paraesthesia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Naloxone
Dosage: 20/10 mg per day
Administration route: Oral
Indication: Complex Regional Pain Syndrome
Start date: 2011-09-17
Lyrica
Dosage: unk
Administration route: Oral
Indication: Complex Regional Pain Syndrome
Start date: 2011-09-17
End date: 2011-01-01
Lyrica
Dosage: 450 mg per day
Administration route: Oral
Start date: 2011-01-01
End date: 2011-10-01
Other drugs received by patient: Flupirtine Maleate; Amitriptyline HCL
|